Table 1 Strategies for cellular immune... | American Society of Hematology

Table 1

Strategies for cellular immune therapy under investigation

Strategy	Phase	Relevant publications
CD154 gene therapy	Phase 1 clinical trial	Biagi et al,³⁰ Wierda et al³¹
Ex vivo T-cell activation	Phase 1 clinical trial	Kipps et al³²
Heteroclytic peptide therapy	Preclinical phase	Trojan et al,³³ Zirlik et al³⁴
DC-based therapy	Phase 1 clinical trial	Hus et al³⁵
CD20-HLA/CMV–targeting complexes	Preclinical phase	Kater et al,³⁶ Mous et al³⁷

Strategy	Phase	Relevant publications
CD154 gene therapy	Phase 1 clinical trial	Biagi et al,³⁰ Wierda et al³¹
Ex vivo T-cell activation	Phase 1 clinical trial	Kipps et al³²
Heteroclytic peptide therapy	Preclinical phase	Trojan et al,³³ Zirlik et al³⁴
DC-based therapy	Phase 1 clinical trial	Hus et al³⁵
CD20-HLA/CMV–targeting complexes	Preclinical phase	Kater et al,³⁶ Mous et al³⁷